Facts About Pediatric Cancers

Here are some facts about pediatric cancers in the United States, according to the National Cancer Institute.

Basic Facts About Pediatric Cancers

About 10,400 children under age 15 are diagnosed with cancer in the United States annually.

Cancer is an extraordinarily rare disease among children. The NCI averages that between one and two children develop cancer each year per 10,000 children in the United States.

Speaking broadly, survival rates among pediatric cancers have gone from under 20 percent in the 1960s to more than 80 percent today.

Nonetheless, cancer is the leading cause of disease-related death among children over the age of 1, with about 1,500 such deaths every year.

Cancer kills more children than muscular dystrophy, AIDS, asthma, juvenile diabetes and cystic fibrosis combined.

Common Diagnoses of Pediatric Cancers

The most commonly diagnosed pediatric cancer is acute lymphoblastic leukemia (ALL). About 2,900 children receive the diagnosis annually in the United States.

Leukemia and central nervous system cancers account for about half of all diagnosed pediatric cancers annually.

The 10 most commonly diagnosed pediatric cancers are:

  • Leukemia (acute lymphoblastic leukemia and acute myeloid leukemia)
  • Central nervous system (CNS), brain and spinal cord tumors
  • Lymphomas, (including Hodgkin's and non-Hodgkin's lymphoma)
  • Skin cancer and melanomas
  • Soft tissue tumors (including rhabdomyosarcoma)
  • Germ cell tumors
  • Neuroblastoma
  • Bone cancers (including osteosarcoma and Ewing sarcoma)
  • Renal cancer (including Wilms tumor)
  • Retinoblastoma

Causes of Pediatric Cancers

The causes of most pediatric cancers remain unknown. Children born with Down syndrome are at increased risk of developing leukemia. Otherwise, a genetic mutation can sometimes be identified that drives the cancer, but the reason for the mutation in almost all circumstances has not been determined. Other suspects include some form of exposure to ionizing radiation in the womb.

Research continues to look into other possible routes, including maternal diet during pregnancy, oral or other types of contraceptives, fertility drugs and possible viral exposures during pregnancy.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap